Corvus Pharmaceuticals, Inc. - COM (CRVS)

Q4 2021 13F Holders as of 12/31/2021

Type / Class
Equity / COM
Number of holders
60
Total Shares
27.7M
Shares change
-495K
Total reported value, excl. options
$66.7M
Value change
-$7.83M
Put/Call ratio
1.08
Number of buys
33
Number of sells
-26
Price
$2.41
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.